These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16802287)

  • 21. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
    Davison BJ; Breckon E
    Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Confidence and uncertainty long after initial treatment for early prostate cancer: survivors' views of cancer control and the treatment decisions they made.
    Clark JA; Talcott JA
    J Clin Oncol; 2006 Sep; 24(27):4457-63. PubMed ID: 16983114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
    Davison BJ; Goldenberg SL
    BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary treatment considerations among men with newly diagnosed prostate cancer.
    Zeliadt SB; Moinpour CM; Blough DK; Penson DF; Hall IJ; Smith JL; Ekwueme DU; Thompson IM; Keane TE; Ramsey SD
    Am J Manag Care; 2010 May; 16(5):e121-30. PubMed ID: 20455638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Finding help for sexual problems after prostate cancer treatment: a phone survey of men's and women's perspectives.
    Neese LE; Schover LR; Klein EA; Zippe C; Kupelian PA
    Psychooncology; 2003; 12(5):463-73. PubMed ID: 12833559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancer.
    Mazur DJ; Merz JF
    J Am Geriatr Soc; 1996 Aug; 44(8):934-7. PubMed ID: 8708303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short- and long-term mortality with localized prostate cancer.
    Merglen A; Schmidlin F; Fioretta G; Verkooijen HM; Rapiti E; Zanetti R; Miralbell R; Bouchardy C
    Arch Intern Med; 2007 Oct; 167(18):1944-50. PubMed ID: 17923593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
    Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
    J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment.
    Boyd BG; McCallum SW; Lewis RW; Terris MK
    Urology; 2006 Oct; 68(4):840-4. PubMed ID: 17070364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
    Yossepowitch O; Eggener SE; Bianco FJ; Carver BS; Serio A; Scardino PT; Eastham JA
    J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "It's a maybe test": men's experiences of prostate specific antigen testing in primary care.
    Evans R; Edwards AG; Elwyn G; Watson E; Grol R; Brett J; Austoker J
    Br J Gen Pract; 2007 Apr; 57(537):303-10. PubMed ID: 17394734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy.
    Cooperberg MR; Freedland SJ; Pasta DJ; Elkin EP; Presti JC; Amling CL; Terris MK; Aronson WJ; Kane CJ; Carroll PR
    Cancer; 2006 Nov; 107(10):2384-91. PubMed ID: 17039503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PCA: prostate cancer, patient-centred approach or both?
    Denis L; Joniau S; Bossi A; Baskin-Bey E; Fitzpatrick JM
    BJU Int; 2012 Jul; 110(1):16-22. PubMed ID: 22233268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of self-referral in men with symptoms of prostate disease.
    Hale S; Grogan S; Willott S
    Br J Health Psychol; 2007 Sep; 12(Pt 3):403-19. PubMed ID: 17640454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of a web-based prostate cancer decision site.
    Moul JW; Esther TA; Bauer JJ
    Semin Urol Oncol; 2000 Aug; 18(3):241-4. PubMed ID: 10975497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.
    Albertsen PC; Hanley JA; Penson DF; Barrows G; Fine J
    J Urol; 2007 Mar; 177(3):932-6. PubMed ID: 17296379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.